id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-0749-0004,FDA,FDA-2026-P-0749,"Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-08T04:00:00Z,2026,5,,,2026-05-08T17:04:13Z,2026-09199,0,0,09000064b92c97d0
FDA-2026-P-0749-0005,FDA,FDA-2026-P-0749,Response Letter,Other,Letter(s),2026-05-08T04:00:00Z,2026,5,2026-05-08T04:00:00Z,,2026-05-09T00:20:08Z,,0,0,09000064b92ca57f
FDA-2026-P-0749-0001,FDA,FDA-2026-P-0749,Citizen Petition from Apotex Inc.,Other,Citizen Petition,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,2026-07-23T03:59:59Z,2026-05-08T20:03:22Z,,1,0,09000064b9182c73
FDA-2026-P-0749-0002,FDA,FDA-2026-P-0749,Acknowledgment Letter from FDA DMB to Apotex Inc.,Other,Acknowledgement Letter/Receipt,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,,2026-01-27T01:06:59Z,,0,0,09000064b9182c75
FDA-2026-P-0749-0003,FDA,FDA-2026-P-0749,Attachment 1 - Orange Book_ Approved Drug Products with Therapeutic Equivalence Evaluations,Supporting & Related Material,Background Material,2026-01-26T05:00:00Z,2026,1,,,2026-01-27T01:07:09Z,,0,0,09000064b9182cfa